Who we work with
MedTech companies at different stages of development, and the investors who back them.
- International manufacturers
- Companies with products on the market elsewhere, planning their first US entry.
- Companies in clinical development
- Teams running feasibility or pivotal trials that need the study to support coverage and launch as well as FDA.
- Companies preparing for launch
- Companies with clearance or approval in sight that need a launch plan, systems and a field team.
- Established companies expanding their portfolio
- Device companies adding a product or indication that need specialist help or extra capacity.
- Investors and portfolio companies
- Investors who want an independent view of what a MedTech company needs to reach the US market.
- Clinicians, researchers and inventors
- Clinical innovators taking a technology from concept toward early feasibility, regulatory strategy and the evidence US commercialization requires.
Planning for the US market?
Tell us about your technology and where it is in development.

